• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    44 Stocks Moving In Thursday's Mid-Day Session

    12/30/21 2:03:02 PM ET
    $AGMH
    $ALLR
    $ANGN
    $API
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGMH alert in real time by email

    Gainers

    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.
    • Future FinTech Group Inc. (NASDAQ:FTFT) jumped 39.8% to $1.72 after the company announced a new blockchain division.
    • CooTek (Cayman) Inc. (NYSE:CTK) rose 30.9% to $0.6935 after gaining more than 6% on Wednesday.
    • Molecular Templates, Inc. (NASDAQ:MTEM) gained 27.9% to $4.31.
    • Pardes Biosciences, Inc. (NASDAQ:PRDS) surged 23.5% to $16.83.
    • Ever-Glory International Group, Inc. (NYSE:EVK) gained 21.7% to $2.7999.
    • Integrated Media Technology Limited (NASDAQ:IMTE) shares jumped 20.6% to $5.44. Integrated Media Technology reported launching of NFT trading platform.
    • Angion Biomedica Corp. (NASDAQ:ANGN) gained 20.5% to $2.8914. Angion Biomedica recently announced topline results from its phase 2 GUARD trial of ANG-3777 in cardiac surgery-associated acute kidney injury.
    • iQIYI, Inc (NASDAQ:IQ) gained 19.6% to $4.82.
    • CareCloud, Inc. (NASDAQ:MTBC) rose 18.8% to $5.95.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) surged 18.6% to $2.74.
    • Youdao, Inc. (NYSE:DAO) gained 18.3% to $11.83.
    • Viracta Therapeutics, Inc. (NASDAQ:VIRX) jumped 16.6% to $3.93.
    • NIO Inc. (NYSE:NIO) shares surged 15.7% to $32.69. Shares of several Chinese stocks, including Nio, traded higher after the Chinese government vowed to focus on consumption recovery and reduce some income tax rates.
    • Agora, Inc. (NYSE:API) gained 15.6% to $17.11.
    • Dada Nexus Limited (NASDAQ:DADA) rose 15.4% to $13.74 after the Chinese government vowed to focus on consumption recovery and reduce some income tax rates.
    • Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) gained 15.3% to $5.59.
    • DouYu International Holdings Limited (NASDAQ:DOYU) rose 15.2% to $2.5806. Shares of several Chinese stocks traded higher after the Chinese government vowed to focus on consumption recovery and reduce some income tax rates.
    • Tencent Music Entertainment Group (NYSE:TME) surged 15% to $6.86 after the Chinese government vowed to focus on consumption recovery and reduce some income tax rates.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 14.7% to $2.3184. Aridis Pharmaceuticals recently announced encouraging preclinical data for pan coronavirus fully human monoclonal antibody (mAb) cocktail AR-701.
    • TAL Education Group (NYSE:TAL) gained 14.5% to $3.94 after the Chinese government vowed to focus on consumption recovery and reduce some income tax rates.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) rose 14.3% to $10.40. Allarity Therapeutics recently submitted a marketing application to the FDA seeking approval for dovitinib for the third-line treatment of renal cell carcinoma (RCC) patients.
    • Autohome Inc. (NYSE:ATHM) gained 14.2% to $29.83. Shares of several companies in the broader media sector traded higher following better-than-expected US jobless claims data, which has lifted recovery sentiment.
    • 360 DigiTech, Inc. (NASDAQ:QFIN) gained 14.2% to $23.01. Shares of several banks and financial services companies traded higher following better-than-expected US jobless claims data, which has lifted recovery sentiment.
    • Bilibili Inc. (NASDAQ:BILI) rose 13.2% to $48.20 after the Chinese government vowed to focus on consumption recovery and reduce some income tax rates.
    • Genius Sports Limited (NYSE:GENI) gained 12.8% to $8.11.
    • So-Young International Inc. (NASDAQ:SY) jumped 12.2% to $3.31 after the Chinese government vowed to focus on consumption recovery and reduce some income tax rates.
    • Reliance Global Group, Inc. (NASDAQ:RELI) rose 11.4% to $6.96. Reliance Global Group recently announced definitive agreement to acquire Medigap Health Insurance Company for $19.6 million in cash and stock.
    • Energy Focus, Inc. (NASDAQ:EFOI) shares gained 9.8% to $4.81 after jumping over 11% on Wednesday. Energy Focus recently entered into definitive securities purchase agreements with institutional investors to sell 1.28 million shares of common stock and warrants to purchase up to 1.28 million shares, in combinations of one share (or one pre-funded warrant) and one warrant for a combined purchase price of $3.52.
    • uCloudlink Group Inc. (NASDAQ:UCL) gained 9.1% to $4.80 after jumping over 15% on Wednesday.
    • BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) rose 6.1% to $2.46. BiondVax reported successful closing of $9.8 million follow-on underwritten offering of ADSs including exercise of the over-allotment.


    Check out these big penny stock gainers and losers

    Losers

    • Vector Group Ltd. (NYSE:VGR) shares dipped 35% to $11.15. Vector Group said it has completed the spin-off of Douglas Elliman Inc. into a standalone, publicly traded company.
    • Puxin Limited (NYSE:NEW) fell 23.7% to $0.4120. Puxin shares jumped 80% on Wednesday after the company reported Q2 earnings results.
    • Takung Art Co., Ltd. (NASDAQ:TKAT) fell 15.9% to $4.38 after jumping around 37% on Wednesday.
    • Pop Culture Group Co., Ltd (NASDAQ:CPOP) fell 15.3% to $2.7601 after climbing 41% on Wednesday.
    • United Time Technology Co., Ltd. (NASDAQ:UTME) shares fell 13.3% to $2.9389 after jumping 47% on Wednesday.
    • Biofrontera Inc. (NASDAQ:BFRI) dipped 12.1% to $7.70. Biofrontera announced reduction of Biofrontera AG shareholding to less than 50% through warrant exercises.
    • Scully Royalty Ltd. (NYSE:SRL) fell 10.8% to $8.93.
    • Cue Health Inc. (NASDAQ:HLTH) dropped 8.6% to $13.01.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 8.5% to $1.2999 after jumping more than 26% on Wednesday.
    • Altamira Therapeutics Ltd. (NASDAQ:CYTO) fell 8.3% to $1.8807. Altamira Therapeutics shares climbed more than 35% on Wednesday after the company issued an update on Bentrio program.
    • AGM Group Holdings Inc. (NASDAQ:AGMH) dropped 8.3% to $2.53.
    • Biogen Inc. (NASDAQ:BIIB) fell 8% to $237.64 after Samsung BioLogics denied its parent company, Samsung Group, is looking to buy Biogen.
    • View, Inc. (NYSE:VIEW) dropped 7.9% to $4.1150.
    Get the next $AGMH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGMH
    $ALLR
    $ANGN
    $API

    CompanyDatePrice TargetRatingAnalyst
    Biogen Inc.
    $BIIB
    2/9/2026$194.00 → $228.00Buy
    H.C. Wainwright
    TAL Education Group
    $TAL
    1/30/2026$18.00Neutral → Outperform
    Macquarie
    Genius Sports Limited
    $GENI
    1/22/2026$10.00Hold
    Stifel
    NIO Inc.
    $NIO
    1/15/2026$6.10Neutral → Outperform
    Macquarie
    Genius Sports Limited
    $GENI
    1/9/2026$16.00Equal Weight → Overweight
    Wells Fargo
    Biogen Inc.
    $BIIB
    1/7/2026$185.00Neutral
    UBS
    Biogen Inc.
    $BIIB
    12/10/2025$143.00Hold → Reduce
    HSBC Securities
    NIO Inc.
    $NIO
    11/25/2025Outperform → Neutral
    Macquarie
    More analyst ratings

    $AGMH
    $ALLR
    $ANGN
    $API
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-15) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211855, Application Classification: Labeling

    3/25/24 4:41:37 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGMH
    $ALLR
    $ANGN
    $API
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Huang Chiao Chieh bought $600,001 worth of shares (262,009 units at $2.29), increasing direct ownership by 23% to 1,421,219 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    12/31/25 9:21:21 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    Chief Executive Officer Huang Chiao Chieh bought $500,000 worth of shares (264,550 units at $1.89), increasing direct ownership by 30% to 1,159,210 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    8/19/25 6:04:55 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    Chief Executive Officer Huang Chiao Chieh bought $400,000 worth of shares (214,124 units at $1.87), increasing direct ownership by 31% to 894,660 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    6/23/25 7:07:01 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    $AGMH
    $ALLR
    $ANGN
    $API
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Head of Development Singhal Priya converted options into 1,829 shares, covered exercise/tax liability with 582 shares and sold $134,116 worth of shares (748 units at $179.30), increasing direct ownership by 9% to 6,271 units (SEC Form 4)

    4 - BIOGEN INC. (0000875045) (Issuer)

    2/3/26 5:17:50 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Graff Jeremy R. was granted 133,333 shares, increasing direct ownership by 54% to 381,644 units (SEC Form 4)

    4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)

    1/16/26 4:13:58 PM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Huang Chiao Chieh bought $600,001 worth of shares (262,009 units at $2.29), increasing direct ownership by 23% to 1,421,219 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    12/31/25 9:21:21 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    $AGMH
    $ALLR
    $ANGN
    $API
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright reiterated coverage on Biogen with a new price target

    H.C. Wainwright reiterated coverage of Biogen with a rating of Buy and set a new price target of $228.00 from $194.00 previously

    2/9/26 6:43:59 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TAL Education upgraded by Macquarie with a new price target

    Macquarie upgraded TAL Education from Neutral to Outperform and set a new price target of $18.00

    1/30/26 6:41:31 AM ET
    $TAL
    Other Consumer Services
    Real Estate

    Stifel initiated coverage on Genius Sports with a new price target

    Stifel initiated coverage of Genius Sports with a rating of Hold and set a new price target of $10.00

    1/22/26 8:29:06 AM ET
    $GENI
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AGMH
    $ALLR
    $ANGN
    $API
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $AGMH
    $ALLR
    $ANGN
    $API
    SEC Filings

    View All

    Biologics License Application for Subcutaneous Formulation of "LEQEMBI®" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China

    TOKYO and CAMBRIDGE, Mass., Feb. 08, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen")) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of "LEQEMBI®" (brand name in China: "乐意保®", generic name: lecanemab), an anti-amyloid beta (Aβ) protofibril antibody, which was accepted in January 2026, has been designated for Priority Review by the National Medical Products Administration (NMPA) of China. The Priority Review and Approval Procedure was implemented

    2/8/26 9:00:00 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    AGMH Announces Strategic Upgrade: Access to Global Top-Tier Storage Chip Supply Chain and Accelerates R&D of AI All-Flash Storage Server Systems

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (NASDAQ:AGMH, "AGMH" or the "Company")), a technology company focus on high-performance computing and frontier innovation, today launched a large-scale strategic procurement initiative targeting leading global semiconductor suppliers. This program focus on securing high-performance enterprise-grade NAND Flash memory and associated controller chips, which will exclusively support AGMH's independently developed all-flash storage server systems designed specifically for AI workloads. This move marks a critical milestone in the Company's efforts to build a robust, high-efficiency AI infrastructure ecosystem. Addressing AI Com

    2/5/26 7:50:00 AM ET
    $AGMH
    EDP Services
    Technology

    Genius Sports Enters into Definitive Agreement to Acquire Legend, Creating a Digital Sports and Gaming Media Powerhouse

    Legend provides a scaled media platform, with world-class marketing technology powering owned and operated digital properties as well as syndication of sports and betting content The acquisition will provide Genius Sports with a unique structural position as the only company operating two synergistic businesses across official sports data and media and advertising Combination will unlock greater scale, stronger margins, and higher cash conversion than previously communicated at Investor Day Genius Sports Limited (NYSE:GENI) ("Genius Sports") today announced it has entered into a definitive agreement ("Agreement") to acquire Legend, a global, digital sports and gaming media network

    2/5/26 6:00:00 AM ET
    $GENI
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 10-K filed by Biogen Inc.

    10-K - BIOGEN INC. (0000875045) (Filer)

    2/6/26 7:36:07 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Biogen Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - BIOGEN INC. (0000875045) (Filer)

    2/6/26 6:55:01 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 6-K filed by Bilibili Inc.

    6-K - Bilibili Inc. (0001723690) (Filer)

    2/6/26 6:01:30 AM ET
    $BILI
    EDP Services
    Technology

    $AGMH
    $ALLR
    $ANGN
    $API
    Leadership Updates

    Live Leadership Updates

    View All

    Appia Announces Appointment of VP Corporate Development

    Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Appia Rare Earths & Uranium Corp. (CSE:API) (OTCQB:APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) (the "Company" or "Appia") is pleased to announce that Jason Bagg has been appointed Vice-President Corporate Development, effective January 15, 2026. Mr. Bagg brings over 25 years of financial and uranium sector experience, including his position as Chief Executive Officer of Urano Energy Corp, and Puranium Energy Ltd. Tom Drivas, CEO of Appia, commented:"On behalf of the Board of Directors, it is my pleasure to welcome Jason to the Appia team. His experience in the financial markets and the uranium sector comes at a pivotal time as the Compa

    1/15/26 7:30:00 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    FTFT Announces Agreement with S1Quant to Explore the New Blue Ocean of Compliant Cryptocurrency Asset Management

    NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Future FinTech Group Inc. (NASDAQ:FTFT, ", Future FinTech", , ", FTFT", , or the ", Company", )), a comprehensive financial and digital technology service provider, today announced that on December 29, 2025, its wholly-owned subsidiary, FTFT International Securities and Futures Limited ("FTFT Securities"), signed a Letter of Intent for Strategic Cooperation agreement (the "Agreement") with S1Quant in the field of cryptocurrency asset management. The two parties have agreed to join hands to establish long-term, in-depth cooperation in the field of cryptocurrency asset management and jointly promote the development of a compliant and professional cryptocu

    1/5/26 8:30:00 AM ET
    $FTFT
    Real Estate

    /C O R R E C T I O N -- National Association of Corporate Directors/

    In the news release, Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors, issued 10-Oct-2025 by National Association of Corporate Directors over PR Newswire, we are advised by the company that the third paragraph, the end of the last line, should read "IBM Business Transformation Services" instead of "IBM Consulting Business Transformation Services" as originally issued inadvertently. The complete, corrected release follows: Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors Seasoned executives bring deep expertise in innovation, governance, and business to strengthen NACD's leadership board excellence WASHINGTON, Oct. 10, 2025 /PRNewswire/ -- Th

    10/10/25 10:00:00 AM ET
    $BIIB
    $IFF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials

    $AGMH
    $ALLR
    $ANGN
    $API
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form SC 13G filed by Genius Sports Limited

    SC 13G - Genius Sports Ltd (0001834489) (Subject)

    11/20/24 1:31:10 PM ET
    $GENI
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Molecular Templates Inc.

    SC 13G/A - Molecular Templates, Inc. (0001183765) (Subject)

    11/18/24 9:49:56 PM ET
    $MTEM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGMH
    $ALLR
    $ANGN
    $API
    Financials

    Live finance-specific insights

    View All

    Genius Sports Enters into Definitive Agreement to Acquire Legend, Creating a Digital Sports and Gaming Media Powerhouse

    Legend provides a scaled media platform, with world-class marketing technology powering owned and operated digital properties as well as syndication of sports and betting content The acquisition will provide Genius Sports with a unique structural position as the only company operating two synergistic businesses across official sports data and media and advertising Combination will unlock greater scale, stronger margins, and higher cash conversion than previously communicated at Investor Day Genius Sports Limited (NYSE:GENI) ("Genius Sports") today announced it has entered into a definitive agreement ("Agreement") to acquire Legend, a global, digital sports and gaming media network

    2/5/26 6:00:00 AM ET
    $GENI
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    TAL Education Group Announces Unaudited Financial Results for the Third Fiscal Quarter Ended November 30, 2025

    BEIJING, Jan. 29, 2026 /PRNewswire/ -- TAL Education Group (NYSE:TAL) ("TAL" or the "Company"), a smart learning solutions provider in China, today announced its unaudited financial results for the third quarter of fiscal year 2026 ended November 30, 2025. Highlights for the Third Quarter of Fiscal Year 2026 - Net revenues were US$770.2 million, compared to net revenues of US$606.4 million in the same period of the prior year. - Income from operations was US$93.1 million, compared to loss from operations of US$17.4 million in the same period of the prior year. - Non-GAAP income from operations, which excluded share-based compensation expenses, was US$104.0 million, compared to non-GAAP loss

    1/29/26 4:00:00 AM ET
    $TAL
    Other Consumer Services
    Real Estate

    Youdao to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11

    HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced that it will report its fourth quarter and fiscal year 2025 financial results on Wednesday, February 11, 2026, before the open of the U.S. markets. The earnings teleconference call with simultaneous webcast will take place at 5:00 a.m. Eastern Time on Wednesday, February 11, 2026 (Beijing/Hong Kong Time: 6:00 p.m., Wednesday, February 11, 2026). Youdao's management will be on the call to discuss the quarterly results and answer questions. Dial-in d

    1/28/26 3:30:00 AM ET
    $DAO
    $NTES
    Other Consumer Services
    Real Estate
    Computer Software: Prepackaged Software
    Technology